Literature DB >> 24144518

Osteoblastoma is a metabolically active benign bone tumor on 18F-FDG PET imaging.

Kusai M Al-Muqbel1, Ma'moon H Al-Omari, Ziad A Audat, Mohammad A Alqudah.   

Abstract

We describe a case of a 9-y-old girl who on (18)F-FDG PET imaging was found to have a highly metabolically active sacral tumor with an average standarized uptake value of 6.2. The tumor was proven to be osteoblastoma by pathologic examination. Osteoblastoma is a relatively rare benign primary bone tumor and occurs predominantly in patients younger than 20 y. The most common area of involvement is the spine. Osteoblastoma has been reported to be metabolically active on (18)F-FDG PET imaging, with an average standarized uptake value of 3.2, which renders (18)F-FDG PET imaging unable to differentiate benign from malignant primary bone tumors. To our knowledge, only 5 cases of osteoblastoma evaluated by (18)F-FDG PET imaging have been reported in the literature; all were metabolically active on (18)F-FDG PET imaging. The objective of this case report is to show that a metabolically active primary bone tumor on (18)F-FDG PET imaging might be benign and not necessarily malignant.

Entities:  

Keywords:  FDG; PET/CT; benign bone tumor; bone; oncology; osteoblastoma

Mesh:

Substances:

Year:  2013        PMID: 24144518     DOI: 10.2967/jnmt.113.127332

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN: 0091-4916


  1 in total

1.  Imaging algorithm and multimodality evaluation of spinal osteoblastoma.

Authors:  Zihuan Huang; Tingsong Fang; Zhiguang Si; Youcai Li; Lan Zhang; Chunling Zheng; Shenmei Li; Manting Su; Xiaomin Liu; Xiaodan Li; Yuankui Wu
Journal:  BMC Musculoskelet Disord       Date:  2020-04-14       Impact factor: 2.362

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.